Bruker Corporation today announced that it has completed its previously announced acquisition of Alicona Imaging GmbH, a leading provider of optical-based metrology products in Graz, Austria. For calendar year 2018, Alicona expects to be profitable with revenues of approximately $25 million. Financial details of the transaction were not disclosed.
Bruker anticipates the acquisition to expand its application reach and offer customers an even more comprehensive selection of complementary metrology solutions to serve materials research, engineering and high-precision quality assurance needs.
Forward Looking Statements for Bruker Corporation
Any statements contained in this press release related to Bruker, Alicona Imaging GmbH and the acquisition of Alicona Imaging GmbH by Bruker which do not describe historical facts may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are often identified by qualifiers such as “expect,” “anticipate,” “will,” and similar expressions. Any forward-looking statements contained in this press release are based on Bruker’s current expectations, but are subject to risks and uncertainties that could cause actual results to differ materially from those indicated. Forward-looking statements in this communication include, among other things, statements about the potential benefits of the transaction, Bruker’s plans, objectives, expectations and intentions, and the financial condition, results of operations and business of Bruker following the completion of the proposed transaction. Risks and uncertainties include, among other things, risks and uncertainties relating to the consummation of the proposed acquisition on the proposed terms and schedule; Bruker’s financial and operational performance following the completion of the proposed transaction; Bruker’s ability to successfully integrate the business and realize the strategic and other benefits of the acquisition; the timing of when the acquisition will be accretive to earnings; and other risk factors identified and described in Bruker’s filings with the Securities and Exchange Commission, including, without limitation, Bruker’s annual report on Form 10-K for the year ended December 31, 2017 and subsequently filed Quarterly Reports on Form 10-Q. Bruker expressly disclaims any intent or obligation to update these forward-looking statements other than as required by law.
Date: December 24, 2018
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Source: yahoo Finance
